Shukra Pharmaceuticals Limited manufactures and markets pharmaceutical products in India and internationally. Its product portfolio includes macrolides, quinolones, anti-bacterial, anti-fungal, anti-malarial, anti-viral, anti-protozoal, anti-anthelmintic, sedative and tranquillizer, anti-depressant, anti-manic, anti-emetic, anti-ulcer, beta blockers, diuretics, analgesic, muscle relaxants, anti-tuberculosis, vitamin products, anti-allergics, corticosteroids, hyper and hypoglycemic, and other products, as well as antibiotics, such as penicillin and cephalosporin. The company was formerly known as Relish Pharmaceuticals Limited and changed its name to Shukra Pharmaceuticals Limited in August 2016. Shukra Pharmaceuticals Limited was incorporated in 1993 and is based in Ahmedabad, India.
| Current Price | ₹29.12 |
|---|---|
| Market Cap | ₹1,280 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Pharmaceutical Products |
| P/E Ratio | 58.2 |
| Return on Equity | 28.89% |
| 52-Week Range | ₹12.97 – ₹65.26 |
| Beta (1Y) | 0.27 |
| Dividend Yield | 0.03% |
1. Pharamaceutical Segment-100%
Shukra Pharmaceuticals Ltd is trading at ₹29.12, with a market capitalisation of ₹1,280 Cr.
Shukra Pharmaceuticals Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Products).
Shukra Pharmaceuticals Ltd has a P/E of 58.2 and a return on equity of 28.89%.